Clinical Trial Update: SRG-514 Administered Intraoperatively to Patients Undergoing Breast-conserving Cancer Surgery [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating intraoperative administration of SRG-514 in patients undergoing breast-conserving surgery for breast cancer; currently activ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• SRG-514

Snippet

Sponsor: SURGE Therapeutics | Conditions: Breast Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING